Clinical Trials Browser

Phase 1 × Withdrawn × belinostat × Clear all

NCT04315155 2020-10-28

BENEFIT

Phase 1 Withdrawn

Adenocarcinoma

NCT02875002 2017-12-22

Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas

Phase 1 Withdrawn

Lymphoma, Recurrence, Lymphoma, T-Cell